Litigation Details for Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
✉ Email this page to a colleague
Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-02-22 |
Court | District Court, D. Delaware | Date Terminated | 2020-10-07 |
Cause | 35:271 Patent Infringement | Assigned To | Leonard Philip Stark |
Jury Demand | None | Referred To | Christopher J. Burke |
Parties | TEVA PHARMACEUTICALS USA, INC. | ||
Patents | 10,004,729; 7,399,488; 7,771,707; 8,449,909; 8,557,291; 8,758,813; 8,840,928; 9,044,398; 9,248,195; 9,592,200; 9,682,075; 9,737,530; 9,763,883; 9,968,598 | ||
Attorneys | Brooke E. Hazan; Douglas R. Weider | ||
Firms | Richards, Layton & Finger, PA; Shaw Keller LLP, I.M. Pei Building | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc.
Details for Collegium Pharmaceutical, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-02-21 | 1 | before the expiration of, Collegium’s U.S. Patents Nos. 7,399,488; 7,771,707; 8,449,909; 8,557,291; 8,758,813…is an action for relief from patent infringement, arising under the patent laws of Title 35, United States…Notice of Patent Certification asserting it intends to launch its copy before Collegium’s patents to its…of infringement of the Asserted Patents under the United States Patent Law, 35 U.S.C. § 271(e)(2)(A). …of infringement of the Asserted Patents under the United States Patent Law, 35 U.S.C. § 271(e)(2)(A). | External link to document | |
2019-09-11 | 107 | Report and Recommendations | x27;"883 patent"), 9,968,598 (the '"598 patent") and 10,004,729 (the '"…infringement of 13 patents: United States Patent Nos. 7,771,707 (the "'707 patent"), 8,449,…"729 patent" and collectively with the other patents, "the asserted patents"). Presently…8,449,909 (the "'909 patent"), 8,557,291 (the "'291 patent"), 8,758,813 (the … "'813 patent"), 8,840,928 (the '"928 patent"), 9,044,398 (the '" | External link to document |
2018-02-21 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 7,771,707 B2; US 8,449,909 …2018 7 October 2020 1:18-cv-00300 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |